Related Experiment Video
Updated: Oct 6, 2025
05:13
Preclinical Model of Prenatal Delta-9-Tetrahydrocannabinol Exposure to Assess Its Impact on Neurodevelopmental Outcomes
Published on: February 28, 2025
383
Implementation of a Prenatal Naloxone Distribution Program to Decrease Maternal Mortality from Opioid Overdose
1The Dartmouth Institute for Health Policy and Clinical Practice, 74 College St, Hanover, NH, 03755, USA. marykateduska@gmail.com.
Maternal and Child Health Journal
|January 14, 2022
Summary
A New Hampshire Ob/Gyn clinic implemented a naloxone distribution program to combat rising maternal mortality from opioid overdoses. The program successfully maintained patient screening and discussions despite COVID-19 challenges.
Area of Science:
- Obstetrics and Gynecology
- Public Health
- Addiction Medicine
Background:
- Maternal mortality rates are rising in the US, with opioid overdoses being a significant factor.
- New Hampshire faces a severe crisis, with 50% of maternal deaths linked to drug overdoses (2016-2017).
- This study addresses the critical need for interventions in maternal care.
Purpose of the Study:
- To report the implementation of a point-of-care naloxone distribution program in an Ob/Gyn clinic in New Hampshire.
- To provide a framework for other clinics to adopt similar naloxone programs.
- To improve outcomes for vulnerable perinatal populations affected by opioid use.
Main Methods:
- Tracked naloxone distribution and calculated screening/discussion proportions.
- Monitored program implementation using statistical process control charts.
- Collected qualitative patient and provider feedback on the program's reception.
Main Results:
- 12 doses of naloxone distributed since April 2020.
- Screening rates remained stable at 73% (moving average), despite pandemic challenges.
- Patient-provider discussions averaged 51% (moving average) and were well-received.
Conclusions:
- The implemented naloxone program serves as a model for other Ob/Gyn clinics.
- While long-term impact on maternal mortality is pending, the program is a vital intervention.
- Naloxone programs in obstetrics enhance care for at-risk perinatal patients.
Related Concept Videos
01:15Opioid Analgesics: Synthetic and Semisynthetic Opioids
489
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
489
01:25Analgesia and Pain Management
902
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
902
01:20Opioid Analgesics: Morphine and Other Natural Cogeners
438
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
438
01:22Opioid Receptors: Overview
2.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
2.2K
01:24Parenteral Anesthetics: Overview
266
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
266
01:18Drug Delivery: Enteral Route
829
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
829